Analyst Ratings for Diebold Nixdorf Inc. (DBD)

Updated: 2017-07-27

Shares of Diebold Nixdorf Inc. (NYSE:DBD) have received a consensus rating of Overweight from Wall Street analysts. About 30 days ago, DBD was issued an average rating of Overweight.

Of the 9 analysts covering the stock, 6 gave it a buy rating, 0 gave an overweight rating, 3 issued a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.

DBD was given price targets by several analysts. The maximum price target given was 32, implying potential capital gains of 38.83 percent. The minimum price target given was 26, implying potential capital losses of 12.8 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

Analysts have revised their earnings estimates downwards for this quarter, by about -75 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is -75 percent. Meanwhile, fiscal year estimates have been revised downwards by -37.68 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -37.87 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 3 analysts made negative revisions. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 3 analysts made negative revisions to their fiscal year's estimates.

In the last 52-weeks, DBD has achieved a high of 31.85 and a low of 19.95. Currently the stock is 15.54 percent higher than its low, and below the high by 27.63 percent. DBD has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The DBD value stock report compares DBD to some of its peers using value stock charts. The stock has a market capitalization of $1.72 billion. DBD is estimated to release their earnings results for the quarter on 0000-00-00, days from today.